Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Kedudukan dalam Saham #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Harga Saham
$59.98
Disegerakkan terakhir: 2024-12-13
Modal Pasaran
$1.22B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Healthcare
Pendapatan untuk Longboard Pharmaceuticals, Inc. (LBPH)
Pendapatan pada Sep 2024 TTM: $-76.34M
Menurut laporan kewangan terkini Longboard Pharmaceuticals, Inc., pendapatan semasa syarikat ialah $-76.34M. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $-43.95M, penurunan berbanding pendapatan pada tahun 2021 yang berjumlah $-27.80M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Longboard Pharmaceuticals, Inc. dari 2020 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-76.34M 40.28%
2023 $-54.42M 23.84%
2022 $-43.95M 58.09%
2021 $-27.80M 93.03%
2020 $-14.40M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -7,009.38%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -2,655.08%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B 5,160.66%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 3,943.54%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH